ES

Elia Stupka

Managing Director at Angelini Ventures

Singapore

Overview 

Elia Stupka is the Managing Director at Angelini Ventures in Singapore, with a background in Science, Computational Biology, and Bioinformatics. He has held leadership roles at Health Catalyst and has extensive experience in advising and partnering with startups in the life sciences and biotechnology sectors. Stupka's career highlights include serving as the Strategic Advisor, SVP, and General Manager of the Life Sciences Business at Health Catalyst, and being a Venture Partner at First Star Ventures, showcasing his expertise in business development, data analysis, and strategic leadership within the startup ecosystem.

Work Experience 

  • Managing Director

    2021 - Current

    Managing Director at Angelini Ventures, a global healthcare venture fund created by the Angelini Industries group to create, invest and shape the healthcare companies of the future

  • Strategic Advisor

    2020

  • SVP and General Manager - Life Sciences Business

    2019 - 2020

    General Manager of the Life Sciences Business Unit, providing solutions at the intersection of the providers and the life science industry, accelerating clinical development and success of new therapies by working with our extensive provider network and the enriched real world data of 100M+ patients within the network to drive improved clinical and financial outcomes.

  • Chief Analytics Officer, SVP - Life Sciences Business

    2018 - 2019

    Providing technology leadership in the area of analytics. Building out a new function located in Cambridge, MA to leverage Health Catalyst aggregated data to accelerate the discovery and development of new therapies.

Health Care DataWorks offers business intelligence solutions and empowers healthcare organizations to optimize their operations.

Raised $4,999,541.00 from Cedars Sinai and MemorialCare Innovation Fund.

  • Innovation Councilor

    2020

Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.

Raised $23,975,000.00 from Bill & Melinda Gates Foundation.

  • Strategic Advisor

    2020

Leapcure offers tools for clinical trial patient recruitment, engagement, and retention.

Raised $125,000.00 from 500 Global and 500 Global.

  • Venture Partner

    2019

  • Strategic Advisor

    2019

Duality empowers organizations to extract business value from sensitive data by enabling secure data collaborations within their ecosystem.

Raised $50,000,000.00 from Intel Capital, Euclidean Capital, NAventures, Hearst Ventures, Team8 and LG Technology Ventures.

  • Strategic Advisor

    2018

  • Strategic Advisor

    2018

  • Strategic Advisor

    2018

Reboot Rx is a nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments.

Raised $1,000,000.00 from Amazon Web Services, The Draper Richards Kaplan Foundation, Lyda Hill and Arnold Ventures.

  • Scientific Advisory Board Member

    2016

Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.

Raised $41,000,000.00 from Michael J. Fox Foundation.

Articles About Elia

Relevant Websites